KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Tax Provisions: 2015-2022

Historic Tax Provisions for Arbutus Biopharma (ABUS) over the last 6 years, with Dec 2022 value amounting to $4.4 million.

  • Arbutus Biopharma's Tax Provisions was N/A to $4.4 million in Q1 2022 from the same period last year, while for Mar 2022 it was -$36.8 million, marking a year-over-year change of. This contributed to the annual value of $4.4 million for FY2022, which is N/A change from last year.
  • Latest data reveals that Arbutus Biopharma reported Tax Provisions of $4.4 million as of FY2022, which was up 135.11% from -$12.7 million recorded in FY2019.
  • Arbutus Biopharma's Tax Provisions' 5-year high stood at $4.4 million during FY2022, with a 5-year trough of -$12.7 million in FY2019.
  • Moreover, its 1-year median value for Tax Provisions was $4.4 million (2022), whereas its average is $4.4 million.
  • In the last 5 years, Arbutus Biopharma's Tax Provisions soared by 82.39% in 2018 and then crashed by 195.56% in 2019.
  • Arbutus Biopharma's Tax Provisions (Yearly) stood at -$4.3 million in 2018, then tumbled by 195.56% to -$12.7 million in 2019, then reached $4.4 million in 2022.